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Although substantial progress has been made in
understanding the mechanisms underlying the ex-
pression of mtDNA-encoded polypeptides, the regu-
latory factors involved in mitoribosome-mediated
synthesis and simultaneous insertion of mitochon-
drial oxidative phosphorylation (OXPHOS) polypep-
tides into the inner membrane of mitochondria are
still unclear. In the present study, disruption of the
mouse Crif1 gene, which encodes a mitochondrial
protein, resulted in a profound deficiency in OXPHOS
caused by the disappearance of OXPHOS subunits
and complexes in vivo. CRIF1 was associated with
largemitoribosomal subunits that were located close
to the polypeptide exit tunnel, and the elimination of
CRIF1 led to both aberrant synthesis and defective
insertion of mtDNA-encoded nascent OXPHOS poly-
peptides into the inner membrane. CRIF1 interacted
with nascent OXPHOS polypeptides and molecular
chaperones, e.g., Tid1. Taken together, these results
suggest that CRIF1 plays a critical role in the inte-
gration of OXPHOS polypeptides into the mitochon-
drial membrane in mammals.
INTRODUCTION
Mitochondrial ribosomes (mitoribosomes) decode the genetic
information supplied by mtDNA to synthesize 13 OXPHOS
proteins at the inner mitochondrial membrane (Sharma et al.,274 Cell Metabolism 16, 274–283, August 8, 2012 ª2012 Elsevier Inc2003). Mitoribosomes have low sedimentation coefficients
(about 55S) and consist of a 28S small subunit (SSU) and
a 39S large subunit (LSU) (O’Brien and Kalf, 1967). The SSU is
involved in decoding mitochondrial mRNA. The LSU harbors
the peptidyl transferase center and the exit tunnel for nascent
OXPHOS polypeptides encoded by mtDNA. Pioneering proteo-
mic analysis and cryo-electron microscopic mapping of bovine
mitoribosomes has provided essential information regarding
the mammalian mitoribosome (Koc et al., 2001; Sharma et al.,
2003; Suzuki et al., 2001a). Mitoribosomes have a higher protein
content than the ribosomes involved in other translation
systems, suggesting that mitoribosome-specific proteins have
replaced RNA structural elements during evolution. Despite
having a lower RNA content, the mammalian mitoribosome is
physically larger than the bacterial ribosomes because of the
new proteins added throughout evolution (O’Brien, 2002). The
identification of these additional proteins in mammalian mitori-
bosomes is critical to understand the regulation of the OXPHOS
system in mammals.
The ribosome is not only responsible for protein synthesis but
also serves as a platform for the association of enzymes and
chaperones that act upon the nascent polypeptides emerging
from the exit tunnel in the LSU. Recent experimental evidence
shows that nascent polypeptides are cotranslationally pro-
cessed by various ribosome-associated factors (Kramer et al.,
2009; Woolhead et al., 2004). In particular, ribosome-associated
factors assist cotranslational protein folding and the targeting
of newly synthesized polypeptides to the membrane (Kramer
et al., 2009). Therefore, it is reasonable to postulate that mitori-
bosomes recruit or associate with other factors involved in the
modification and folding of nascent OXPHOS polypeptides. In
fact, recent studies show that mitoribosomes associate with
factors that are critical for intramitochondrial protein synthesis.
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studies suggest that unidentified mitoribosome-specific novel
components may play a critical role in intramitochondrial protein
synthesis in mammals by regulating the chaperoning of nascent
OXPHOS polypeptides.
In the present study, we characterized a mitochondrial factor,
CRIF1, which is essential for intramitochondrial production and
the subsequent insertion of OXPHOS polypeptides into the inner
mitochondrial membrane. CRIF1 interacts with LSU proteins,
some of which surround the exit tunnel of the mitoribosome,
and also interacts with nascent OXPHOS polypeptides and the
mitochondrial-specific chaperone Tid1. The essential role of
CRIF1 in mitochondrial synthesis and membrane integration of
OXPHOS polypeptides was shown in brain-specific Crif1-defi-
cient mice, which exhibited profound OXPHOS failure and
marked neurodegeneration.
RESULTS
CRIF1 Transport into and Localization in Mitochondria
CRIF1 was originally identified as a CR6/gadd45-interacting
protein (Chung et al., 2003), and its homologs are highly
conserved amongmetazoa, but not in yeast (Figure S1A). Protein
sequence analysis predicts a cleaved sequence located in the
N-terminal region in metazoan CRIF1, which may serve as a
mitochondrial targeting sequence (MTS) (Figures 1A and S1A–
S1C). Immunofluorescence staining of endogenous CRIF1 anti-
body revealed that CRIF1 was present in the cytoplasm in all
cells, with approximately 10% of cells also showing staining in
both the mitochondria and the nucleus (Figure 1B). A CRIF1-
GFP construct in which CRIF1 was tagged with GFP at its
C-terminal region was primarily localized in the mitochondria,
with some fluorescence also being seen in the nuclei. In contrast,
N-terminal GFP-tagged CRIF1 (GFP-CRIF1) was only detected
in the nuclei, suggesting that GFP tagging at the N-terminal
region might prevent proper trafficking to the mitochondria
(Figure 1C). To examine whether the MTS in the N-terminal
region of CRIF1 leads to its mitochondrial localization, we gener-
ated an MTS-ligated GFP construct, CRIF1 (MTS)-GFP, that
included a 35 aa CRIF1 MTS at the N terminus of GFP. CRIF1
(MTS)-GFP was exclusively localized in the mitochondria,
whereas CRIF1 (DMTS)-GFP, an MTS-deleted CRIF1, was local-
ized in the nuclei, indicating that the 35 aa MTS of CRIF1 is
required for mitochondrial targeting (Figure 1C).
To verify the mitochondrial localization of CRIF1, cellular
subfractions were subjected to western blotting. CRIF1 was
detected mostly in the mitochondrial fractions (Figure 1D).
Subfractionation experiments using isolated mitochondria re-
vealed that CRIF1 was associated with the inner membrane of
the mitochondria (Figure 1E). We next examined the import of
recombinant [35S]-methionine-labeled human CRIF1 into iso-
lated rat liver mitochondria (Figure 1F) (Park et al., 2007). Import
of full-length CRIF1 into mitochondria generated a processed
form of lower molecular weight, showing that the targeting
sequence is cleaved after import. The generation of this cleaved
CRIF1 protein was completely inhibited by the addition of
the mitochondrial depolarizing agent CCCP (carbonyl cyanide
3-chlorophenylhydrazone), suggesting that CRIF1 cleavage
occurs after import into the mitochondrial matrix. Additionally,Celfull-length CRIF1 was degraded by trypsin treatment, but trans-
located CRIF1 was resistant to trypsin treatment (Figure 1F).
These findings suggest that CRIF1 is imported into the mito-
chondrial matrix and associates with the inner membrane.
Loss of CRIF1 Causes a Drastic Decrease of OXPHOS
Subunits In Vivo
The function of CRIF1 in mitochondria was analyzed in vivo
using conditional knockout mice generated by homologous
recombination. Brain-specific Crif1 knockout mice were gener-
ated by breeding floxed Crif1 female mice with male mice ex-
pressing Cre-recombinase under the control of the CamKII
promoter. These brain-specific Crif1 knockout animals exhibited
locomotion disabilities at 12 weeks and showed markedly short-
ened life spans, with a maximum longevity of 24 weeks (Figures
S2A and 2B). In situ hybridization of Crif1 mRNA in the brain
demonstrated widespread expression in the cerebrum and
cerebellum, but showed the highest expression in the hippo-
campus and dentate gyrus (Figure S2C). Serial histological
sections from brain-specific Crif1 knockout mice showed early
characteristic changes of neuronal degeneration in the CA1
region of the hippocampus at 12 weeks (Figure 2A). At this
stage, hippocampal neuronal cells showed increased TUNEL
staining, suggesting apoptotic neuronal death (Figure 2B).
At approximately 16 weeks, the entire hippocampal region
showed considerable neurodegenerative changes, and the
cerebral cortex exhibited significant levels of neurodegeneration
(Figure 2A).
To examine deficiencies in mitochondrial function in the
cerebral cortex and hippocampus of brain-specific Crif1
knockout mice, two mice (MT1 and MT2) showing neurological
defects were selected for analysis of OXPHOS complexes (Fig-
ure 2C). Blue native-PAGE (BN-PAGE) analysis of mitochondria
isolated from the cortex (Crx) or hippocampus (Hippo) showed
that the assembly of super complexes and complexes I, IV,
and V was markedly reduced inCrif1 knockout mice. Expression
of OXPHOS subunits belonging to complexes I and IV was
decreased in the cortex and hippocampus of the mutant mice
(Figure 2D). Transmission electron microscopy images of mito-
chondria in the hippocampus of 12-week-old Crif1 knockout
mice showed striking morphological abnormalities, including
a loss of electron dense material from the matrix and distorted
or reduced numbers of cristae (Figure 2E). Overall, the findings
from brain-specific Crif1 knockout mice suggested that the
loss of CRIF1 function results in striking and fatal neurodegen-
eration associated with a severe deficiency of OXPHOS
subunits.
Impaired Mitochondrial OXPHOS Function
in Crif1-Deficient Cells
To explore the role of CRIF1 in mitochondria, we examined
mitochondrial function in wild-type (WT, +/D) and Crif1-deficient
(-/D) mouse embryonic fibroblasts (MEFs). Crif1-deficient
cells (Crif1-/D) were generated from fibroblasts prepared from
Crif1-/flox mice by infecting the cells with a retrovirus that
expresses Cre-recombinase (Figure 3A) (Kwon et al., 2008). To
directly evaluate the mitochondrial function of CRIF1, oxygen
consumption rates (OCR) in the WT and Crif1-/D MEF cells
were measured. The basal OCR in the Crif1-/D cells was 18%l Metabolism 16, 274–283, August 8, 2012 ª2012 Elsevier Inc. 275
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Figure 1. CRIF1 Transport into and Localization in Mitochondria
(A) Schematic representation of CRIF1 domains based on the primary structure of CRIF1.
(B) Immunofluorescence of endogenous CRIF1. HeLa cells were immunostained for CRIF1 (red) and Tom20 (green). Scale bar, 10 mm.
(C) Confocal microscopy of HeLa cells transfected with GFP-tagged human CRIF1. CRIF1-GFP, GFP sequence introduced at the C terminus of CRIF1;
GFP-CRIF1, GFP sequence introduced at the N terminus of CRIF1; CRIF1(MTS)-GFP, the MTS (aa 1–35) of CRIF1 was added to the GFP N terminus;
CRIF1(DMTS)-GFP, GFP was added to the C terminus of MTS (1–15)-deleted CRIF1. Scale bar, 20 mm.
(D) Western blot analysis following subcellular fractionation of MEFs. WCE, whole cell extract; Cyt, cytosolic fraction; Mt, mitochondrial fraction; Nuc, nuclear
fraction.
(E) Western blot analysis following subfractionation of mitochondria isolated fromMEFs. OM, outer membrane; IMS, intermembrane space; IM, inner membrane;
MA, matrix.
(F) Mitochondrial protein import assay. Radiolabeled recombinant full-length human CRIF1 was incubated with isolated rat liver mitochondria. p, unprocessed
precursor form; m, mature form.
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CRIF1 Regulates OXPHOS Generationof the value in WT cells (Figure 3B). More importantly, the OCR
in Crif1-/D cells did not respond to treatment using chemical
inhibitors of mitochondrial respiratory chains (Figure 3B). The
marked decrease in the OCR and mitochondrial JC-1 incorpora-
tion (Figure 3C) in Crif1-/D cells suggests that the mitochondria
in these cells are depolarized and dysfunctional. Crif1-/D cells
exhibited higher mitochondrial superoxide levels (Figure 3D).276 Cell Metabolism 16, 274–283, August 8, 2012 ª2012 Elsevier IncHowever, within 4 days after selection, the ATP level in the
Crif1-/D cells did not differ from that in WT cells in a high glucose
medium. In contrast, Crif1-/D cells presented decreased ATP
levels when grown in a glucose-free medium, suggesting that
enhanced glycolysis in Crif1-/D cells is a major pathway for
cellular ATP production (Figure 3E). Analysis of the medium
from cultured Crif1-/D cells showed a marked increase in lactate.
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Figure 2. CRIF1 Deficiency Caused Neurodegeneration Associated with a Drastic Decrease of OXPHOS Subunits In Vivo
(A and B) H&E (A) and TUNEL (B) staining of the hippocampus from 12-week-old mice. Hi, hippocampus; CA, cornu ammonis; DG, dentate gyrus.
(C) BN-PAGE analysis of OXPHOS complexes. Mitochondria isolated from the cortex (Crx) or hippocampus (Hippo) were solubilized with n-dodecyl-b-D-mal-
toside to assess the steady-state levels of OXPHOS complexes (*, ATP synthase subcomplex).
(D) Western blot analysis of the indicated OXPHOS subunits.
(E) Transmission electron microscopy of the hippocampal region. Black squares indicate the enlarged regions. Scale bar, 500 nm.
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with enhanced glycolysis (Figure S3A). Eventually, the Crif1-/D
cells exhibited accelerated cell death (Figure S3A). The
decreased oxygen uptake and enhanced anaerobic glycolysis
observed in Crif1-/D cells suggests that mitochondrial OXPHOS
function is impaired. Therefore, we measured the activity of
OXPHOS complexes in Crif1-/D MEFs compared to WT cells
(Figure 3F). Crif1-/D cells exhibited markedly decreased activi-
ties, as normalized to citrate synthase activity, of complexes I,
III, IV, and V but not complex II (Figure 3F). Electron microscopy
demonstrated that Crif1-/D cells possessed slightly increased
numbers of mitochondria, but the electron density of the mito-
chondrial matrix was reduced (Figure 3G). The mitochondria of
Crif1-/D cells showed structural abnormalities characterized byCelmarked intracristal swelling in all observed mitochondria (Fig-
ure 3G). The cristae of the inner membrane contain a high density
of OXPHOS complexes (Vogel et al., 2006), and the ultrastruc-
tural abnormalities seen in the cristae are consistent with
impaired OXPHOS complexes in Crif1-/D cells.
Loss of OXPHOS Subunits and Complexes
in Crif1-Deficiency
To further characterize the cause of the OXPHOS dysfunction
in Crif1-/D cells, we quantified the amounts of mtDNA and
OXPHOS subunits in WT and Crif1-/D cells. The mtDNA content
did not differ significantly (Figure 3H), but the levels of OXPHOS
subunits in complexes I, III, and IV originating from both
nuclear and mitochondrial genomes were strikingly decreasedl Metabolism 16, 274–283, August 8, 2012 ª2012 Elsevier Inc. 277
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Figure 3. Marked OXPHOS Dysfunction and Loss of OXPHOS Subunits and Complexes in Crif1-Deficient Cells
(A) Generation of Crif1-deficient (Crif1-/D) cells by infecting MEFs with a retrovirus carrying Cre-recombinase. The upper two panels show CRIF1 protein and the
lower two panels show Crif1 mRNA. +/D, WT MEFs; -/D, Crif1-deficient MEFs.
(B) Oxygen consumption rates measured using a Seahorse XF-24 flux analyzer. n = 4. Error bars indicate SD; **p < 0.01.
(C) Ratio of red/green fluorescence of JC-1 as a measure of mitochondrial membrane potential. n = 3. Error bars indicate SD; **p < 0.01.
(D) Fluorescence of MitoSox as a measure of mitochondrial ROS levels. n = 3. Error bars indicate SD; **p < 0.01.
(E) ATP content. n = 5. Error bars indicate SD; **p < 0.01.
(F) Measurement of the activities of mitochondrial OXPHOS complexes normalized to citrate synthase (CS) activity. n = 3. Error bars indicate SD; *p < 0.05,
**p < 0.01.
(G) Transmission electron microscopy shows differences in the appearance of mitochondria. Scale bar, 100 nm.
(H) Relative mtDNA content. n = 3.
(I and J) Western blot analysis of OXPHOS subunits encoded by nDNA (I) and mtDNA (J).
(K and L) BN-PAGE analyses of OXPHOS complexes. Isolated mitochondria were solubilized with n-dodecyl-b-D-maltoside (K) or digitonin (L) to assess the
steady-state levels of OXPHOS complexes and supercomplexes, respectively (*, ATP synthase subcomplex).
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CRIF1 Regulates OXPHOS Generationin Crif1-/D cells (Figures 3I and 3J). Complex II was an exception
to this pattern, as it is assembled from subunits from the
nuclear genome (Figure 3I). Moreover, BN-PAGE analysis re-
vealed that OXPHOS complexes I, III, IV, and V were
completely dissociated in Crif1-/D cells (Figure 3K). Three of
the respiratory complexes, I, III, and IV, which are responsible
for the transfer of electrons from NADH, are assembled into
supercomplexes (I+III, III+IV, and I+III+IV) that are not associ-
ated with complex II (Acı´n-Pe´rez et al., 2008; Dudkina et al.,
2005). Crif1-/D cells consistently lacked supercomplex forma-
tion (Figure 3L). Although western blot and BN-PAGE analyses
revealed markedly decreased stability and defective assembly
of OXPHOS subunit proteins in Crif1-/D cells, transcripts of
OXPHOS subunits remained at similar or increased (ND1) levels
in Crif1-/D cells relative to WT cells (Figure S3B). Therefore, the
defective OXPHOS functions in Crif1-/D cells are not due to
impaired transcription of OXPHOS component genes, suggest-
ing that CRIF1 functions in the posttranscriptional biogenesis
of OXPHOS complexes.
Abnormalities in cardiolipin biosynthesis cause OXPHOS
deficiency (Zhang et al., 2011). To assess this possibility, we
measured and compared the cardiolipin levels in both WT
and Crif1-/D cells (Figure S4). The level of cardiolipins contain-
ing (C18:2)3(C18:3)1, (C18:2)4, and (C18:2)3(C18:1)1 did not
decrease in Crif1-/D cells; however, (C18:2)2(C18:1)2 levels did
show a slight decrease. These findings indicate that OXPHOS
deficiency is not a secondary effect of abnormal cardiolipin
biosynthesis in mitochondria.
CRIF1 Associated with LSU of the Mitoribosome
The loss of mitochondrial OXPHOS subunits observed in
Crif1-deficient cells motivated us to further analyze mitochon-
drial ribosomes in these cells. The expression levels of the
essential 12S and 16S mitoribosomal RNAs were comparable
between WT and Crif1-/D cells (Figure 4A). To understand why
OXPHOS function was impaired in the absence of defects in
mtDNA transcription, mitoribosomal RNA, we analyzed the
integrity of the mitoribosome in WT and Crif1-/D MEF cells. In
gradient sedimentation analysis of mitochondrial extracts from
MEFs, MRPS34 and MRPL20 were used as markers of the
small (28S) and large (39S) subunits of the mitoribosome,
respectively. Comigration of MRPS34 and MRPL20 was used
as an indicator of correctly assembled 55S mitoribosomes.
CRIF1 comigrated with assembled 55S mitoribosomes and
with the 39S large ribosomal subunits, suggesting that CRIF1
interacts with the LSU of the mitoribosome (upper panel; Fig-
ure 4B). Interestingly, analysis of ribosome association patterns
in Crif1-/DMEFs showed a decrease in assembled 55S mitoribo-
somes (lower panel; Figure 4B). However, the sedimentation of
the mitoribosome subunits SSU and LSU from Crif1-/D MEFs
was identical to that of SSU and LSU from WT cells. This result
suggests that the loss of CRIF1 does not affect ribosome bio-
genesis, but qualitative defect or loss of stability of the mitoribo-
some could cause a decrease in intersubunit assembly.
Aberrant Mitochondrial Synthesis of OXPHOS Subunits
in Crif1-Deficient MEFs
Next, we investigated the role of CRIF1 in polypeptide synthesis
of mtDNA-encoded OXPHOS subunits by performing pulse-Celchase experiments with mtDNA-encoded OXPHOS subunits in
WT and Crif1-/D MEFs. The amount of newly synthesized mito-
chondrial products was reduced at 1, 2, and 4 hr pulse-labeled
Crif1-/D MEFs (Figure 4C). The subsequent chase showed that
the amount of labeled products was also reduced in Crif1-/D
MEFs. The observed OXPHOS deficiency induced by reduced
protein synthesis in Crif1-/D MEFs prompted us to investigate
de novo protein synthesis in isolated mitochondria. Organelle
translation assays using mitochondria isolated from Crif1-/D
MEFs showed reduced amounts and aberrant patterns of
nascent translation products (Figure 4D). Based on the pulse-
chase and organelle translation experiments, CRIF1 deficiency
results in reduced and aberrant intramitochondrial synthetic
activity of nascent OXPHOS polypeptides in Crif1-/D MEFs.
CRIF1 Deficiency Causes Loss of Insertion of
Mitochondrial OXPHOS into the Inner Membrane
Crif1-/Dcells showed reduced and aberrant synthetic activities.
However, this was not as marked as the complete loss of oxygen
consumption (Figure 3B) and OXPHOS complexes in western
and BN-PAGE (Figures 3I, 3J, 3K, and 3L). Next, we investigated
whether the labeled products in Crif1-/Dcells were adequately
incorporated into the inner membrane. Translation products
were labeled in isolated mitochondria and were extracted
by incubating the mitochondria with carbonate and urea. The
extractable soluble and nonextractable membrane-embedded
proteins were separated by the membrane flotation method
using sucrose gradient ultracentrifugation (Bauerschmitt et al.,
2008; Ott et al., 2006). The translation products in Crif1+/D
MEFs were mostly observed in the membrane fraction; however,
Crif1-/Dcells did not show integration of the translation products
into the inner mitochondrial membrane (Figure 4E). To prove
whether the labeled polypeptides in the soluble fraction of
Crif1-/D MEFs were OXPHOS subunits encoded by mtDNA, we
performed nanoLC-ESI-MS/MS analysis on the translation
products after [13C5,
15N]-methionine labeling during the
translation reaction in isolated mitochondria. Proteomic iden-
tification of trypsin-digested fragments of soluble fraction of
Crif1-/D MEFs revealed mtDNA-encoded OXPHOS subunits
including ND5, COX I, ND4, ND1, and COX II (* in left lane in
Figure 4E). Again, these findings suggest that the absence of
CRIF1 causes loss of insertion into the inner mitochondrial
membrane.
To determine the components of the mitoribosome that
interact with CRIF1, we isolated mitochondria from HeLa cells,
followed by the immunoprecipitation of endogenous CRIF1.
LC-MS/MS analysis of the immunoprecipitated fractions identi-
fied a number of proteins, including large mitoribosomal sub-
units and chaperones, which interacted with CRIF1 (Table S1).
The large subunit components, MRPL23, L28, and L44, which
surround or are positioned close to the polypeptide exit tunnel
in mitoribosome, were present in the immunoprecipitates ob-
tained using an anti-CRIF1 antibody. Interestingly, homologs of
proteins reported to be molecular chaperones, DnaJ (Hsp40)
and heat shock 70 kDa (HSP70), were identified as the interact-
ing proteins.
To establish whether CRIF1 is required for posttranslational
processing of nascent polypeptides, we labeled nascent
OXPHOS polypeptides in isolated mitochondria andl Metabolism 16, 274–283, August 8, 2012 ª2012 Elsevier Inc. 279
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Figure 4. Impaired Mitochondrial Synthesis of OXPHOS Subunits in Crif1-Deficiency
(A) Northern blot analysis of ribosomal RNA from nuclear and mitochondrial DNA. nDNA, nuclear DNA; mtDNA, mitochondrial DNA. +/D, WT MEFs; -/D,
Crif1-deficient MEFs.
(B) Western blot analysis of mitochondrial ribosomes fractions by density sucrose gradient sedimentation.
(C) Pulse-chase labeling of newly synthesized OXPHOS subunits from mtDNA of MEFs.
(D) Organelle translation assay using mitochondria isolated from MEFs.
(E) Mitochondrial membrane flotation analysis of the organelle translation products.
(F) Immunoprecipitation of CRIF1 and detection of nascent polypeptides from mitochondrial DNA.
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shown in Figure 4F, CRIF1 interacted with several nascent
OXPHOS polypeptides, including COX1, cyt b, ND2, ND1, and
COXII. Crif1-/D MEFs showed increased expression of the
mitochondrial chaperones Tid1 and mtHSP70 (Figure 4G), indi-
cating that an absence of CRIF1 stimulates the physiological
molecular chaperone responses. In fact, we found that Tid1
was present in the CRIF1 immunoprecipitates (Figure 4H). Taken
together, these results suggest that CRIF1 is critical for the trans-
lational and cooperative posttranslational integration of nascent
OXPHOS subunits into the inner mitochondrial membrane by
interacting with professional molecular chaperones, including
Tid1 (Figure 4J).
When CRIF1 was restored to the mitochondria of CRIF1
knockout MEFs by an infecting CRIF1-HA adenovirus, the level
of OXPHOS subunits returned to WT levels as indicated by
western blot analysis (Figure 4I). Expression of HA-CRIF1, which
localized exclusively to the nucleus, was not able to rescue the
loss of OXPHOS subunits in Crif1-/D MEFs (Figure 4I).
DISCUSSION
Impaired synthesis of mtDNA-encoded OXPHOS subunits is an
important cause of human mitochondrial disease (Tucker et al.,
2011). The machinery that regulates the expression of mam-
malian mtDNA has only been partly identified, despite being
essential for the regulation of cellular respiration in response
to physiological demands and disease states. Here, we
showed that CRIF1 is essential for the formation of OXPHOS
complexes as evidenced by the profound loss of de novo
intramitochondrial synthesis and the severe dysfunction of
OXPHOS in vivo in CRIF1-deficient cells. CRIF1 contains
several functional domains, including a mitochondrial targeting
sequence, a nuclear localizing signal and coiled-coil domains.
Although it was reported that CRIF1 shows nuclear activity
(demonstrated by the overexpression of N-terminally tagged
recombinant proteins, which were uniformly targeted to the
nucleus; (Chung et al., 2003), the true physiological function
of CRIF1 remains unclear. Recently, Richter et al. found that
CRIF1 interacts with FLAG-tagged ICT1, a peptidyl-tRNA
hydrolase that controls the hydrolysis of prematurely termi-
nated peptidyl-tRNA moieties near the polypeptide exit site in
the large subunit of the mitoribosome (Richter et al., 2010).
Although a cooperative role between ICT1 and CRIF1 has not
been evaluated, this observation supports the findings of the
present study that show that CRIF1 interacts with the large
subunit of the mitoribosome.
Interestingly, CRIF1 also interacted with coiled-coil-containing
LSUs (e.g., MRPL23), which form a structure surrounding the
polypeptide exit tunnel (Kramer et al., 2002; Sharma et al.,
2003). In fact, much of the exterior surface of the mitochondrial
LSU is covered with mitochondria-specific ribosomal proteins,
and the functional region around the polypeptide exit tunnel(G) Western blot analysis of mitochondrial chaperones.
(H) Immunoprecipitation of endogenous CRIF1 and western blot analysis of mito
(I) Western blot analysis of OXPHOS subunits inCrif1-deficient MEFs re-expressin
tagged CRIF1 adenovirus; CRIF1-HA, C-terminal HA-tagged CRIF1 adenovirus.
(J) Schematic model of CRIF1 action in mitoribosome-mediated synthesis of OX
Celdiffers greatly between the mitoribosome and bacterial ribo-
somes (Sharma et al., 2003). CRIF1 homologs are highly
conserved among metazoa, but are not found in yeast or
bacteria (Figure S1A). Based on these findings, we suggest
that CRIF1 is a new mitoribosome-associated factor involved
in the integration of OXPHOS complexes into the mitochondrial
membrane of metazoa. The original screening of mitoribosomal
subunits did not detect CRIF1 as a structural component of the
LSU (Koc et al., 2001; Suzuki et al., 2001b). Because CRIF1 is
rich in Lys residues, which may produce too many small tryptic
peptides, it may not be detected by the LC-MS/MS method
used for proteomic studies on the mammalian mitoribosome.
However, the normal biogenesis of LSU in the absence of
CRIF1 (Figure 4B) suggests that CRIF1 may not be an essential
component in the assembly of the mitoribosome. Therefore,
the definitive assignment of CRIF1 as a new element of the
mitoribosomal LSU needs to be confirmed by reanalyzing
purified preparations of bovine mitoribosomes followed by
structural analysis; however, this is beyond the scope of the
current study.
One of the most fundamental questions regarding the bio-
genesis of OXPHOS complexes is how the OXPHOS polypep-
tides are inserted into the inner membrane and assembled into
oligomeric complexes. The polypeptide exit tunnel of the mitor-
ibosome, where the nascent OXPHOS polypeptide leaves the
ribosomal interior, may be of crucial importance for the recruit-
ment of chaperones. In fact, it was recently discovered that
L23 serves as the central anchor point for bacterial chaperones
(Kramer et al., 2002). Interestingly, we showed that MRPL23,
a component of the mitoribosome exit site, interacts with
CRIF1. Taken together, these findings suggest that CRIF1-
mediated recruitment of DnaJ and HSP70 homologs may
provide crucial chaperone capacity for the correct folding of
nascent OXPHOS polypeptides for assembly into the inner
mitochondrial membrane. Several questionsmay arise regarding
the mechanistic action of CRIF1-recruited chaperones on
the translation, stability, and insertion of OXPHOS subunits.
Crif1-deficient cells or mitochondria showed profound failure
of OXPHOS subunit synthesis in pulse labeling and in organelle
translation assays. Although the loss of CRIF1-mediated
chaperone capacity may stall the activity of translating mitori-
bosomes, the accelerated breakdown of misfolded or unfolded
nascent peptides may be another cause of OXPHOS deficiency.
Collectively, the results in this study suggest that defective
insertion of newly synthesized mitochondrial OXPHOS poly-
peptides into the mitochondrial membrane may result in both
incomplete intersubunit assembly and reduced translation
activities of mitoribosomes associated with the inner mitochon-
drial membrane.
Recently, mitochondrial OXPHOS dysfunction has been
implicated in many common degenerative diseases such as dia-
betes, Parkinson’s disease, and neuromuscular degeneration
(Devine et al., 2011; Park et al., 2006). The role played bychondrial chaperones.
g exogenous CRIF1. GFP, control-GFP adenovirus; HA-CRIF1, N-terminal HA-
PHOS polypeptides.
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implications for mitochondrial diseases and also stimulate
further studies to develop therapeutics against these diseases.
EXPERIMENTAL PROCEDURES
Cells
Wild-type and Crif1-deficient MEF cells were grown in DMEM (Invitrogen) sup-
plemented with 10% FBS (GIBCO) and 1% penicillin streptomycin (GIBCO) at
37C and 5% CO2.
Animal Experiments
Floxed Crif1 (Crif1flox/flox) mice were generated as described previously (Kwon
et al., 2008). CamKII-Cre transgenic mice were purchased from the Jackson
Laboratory (www.jax.org) and maintained in our animal colony under insti-
tutional guidelines of the Korean Research Institute of Biotechnology and
Bioscience and Chungnam National University. CamKII-Cre;Crif1flox/flox mice
were generated by mating Crif1flox/flox mice with CamKII-Cre;Crif1+/flox mice.
All mouse experiments were performed in the animal facility under our institu-
tional guidelines.
Immunocytochemical Studies
The primary antibody used against endogenous CRIF1 was goat anti-human
CRIF1 (Santa Cruz, sc-103443, sc-103445). Secondary antibodies (goat
anti-mouse, donkey anti-goat) conjugated with Alexa Fluor dyes were ob-
tained from Invitrogen. Specimens were analyzed using an LSM 510 META
(Carl Zeiss AG) microscope.
Subcellular Fractionation, Mitochondrial Subfractionation and
Western Blot Analysis
Cultured MEFs were homogenized with a Teflon-glass homogenizer. The
mitochondrial fractions were obtained from the homogenate with differential
centrifugations, and it was subfractionated further by ultracentrifugation
(Kang et al., 2007; Yu et al., 2002). Western blot analysis was performed
according to standard methods with commercially available antibodies as
described in Supplemental Experimental Procedures.
Pulse-Chase Labeling
Pulse-chase labeling was performed as previously described (Weraarpachai
et al., 2009). Cells were pulse-labeled with 200 uCi/ml of an [35S] EasyTag
methionine/cysteine mix (PerkinElmer) for 1–4 hr at 37C in a CO2 incubator
in methionine/cysteine-free DMEM containing 100 ug/ml of emetine. After
labeling, the cells were chased for 10 min in normal DMEM. Then, cellular
protein were separated on 15%–20% polyacrylamide gradient gel and de-
tected by Bio-Imaging analyzer (BAS-3000; Fuji).
Organello Translation Assay
An organelle translation assay was performed as described previously
(Metodiev et al., 2009) with some modifications. Mitochondria from MEFs,
cortices and hippocampi were incubated with EasyTagTM L-[35S]-Methionine
(0.5 mCi/ml) (PerkinElmer), and translation was allowed to proceed for 60 min
at 30C. Mitochondrial pellets were resuspended in SDS-PAGE loading
buffer and subjected to 15%–20% Large SDS-PAGE. After the running, gel
was washed and dried. The labeled mitochondrial translational products
were detected by Bio-Imaging analyzer (BAS-3000; Fuji).
Analysis of Mitoribosomal Subunits
Analysis of 28S, 39S, and 55S mitoribosomal subunits was performed by
sucrose density gradient ultracentrifugation (Metodiev et al., 2009). Subribo-
somal particles were detected using antibodies specific for individual proteins
from the 28S and 39S ribosomal subunits.
Mitochondrial Membrane Flotation Analysis
Membrane flotation analysis of mitochondrial translation products was per-
formed as previously described with some modifications (Bauerschmitt
et al., 2008; Ott et al., 2006). Mitochondria (500 mg) were labeled using the
method, which was applied in organelle translation assay and incubated282 Cell Metabolism 16, 274–283, August 8, 2012 ª2012 Elsevier Incwith extraction buffer (0.1 M sodium carbonate, 4.5 M urea). The samples
were mixed with 2 M sucrose buffer (2 M sucrose in extraction buffer) to
yield a final sucrose concentration of 1.6 M and were centrifuged in a SW60
Ti rotor for 15 hr at 165,000 3 g at 4C. Fractions were collected from the
bottom of the gradients using a Model 2110 Fraction Collector (Bio-Rad)
and the fractions were precipitated with 12% trichloroacetic acid. Samples
were analyzed by SDS-PAGE and detected using a Bio-Imaging analyzer
(BAS-3000; Fuji).
Statistical Analyses
Data are presented as the mean ± standard deviation (SD). The statistical
significance of the comparisons was determined using Student’s two-tailed
t test. A p value less than 0.05 was considered statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, one table, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article online at http://dx.doi.org/10.1016/j.cmet.2012.06.012.
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